Ukrainian pharmaceutical company Farmak plans to register its products in Malaysia by late 2018, Farmak Business Development Director Oleh Siarkevych reported.
He said that first the company intended to bring its strategic products to new markets, in particular, insulin and Amizonum created by the company.
In addition, the company plans to offer its ophthalmological portfolio to the Malaysian market, as well as contrast medium. (Interfax/Business World Magazine)
